ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AXSM Axsome Therapeutics Inc

68.59
0.00 (0.0%)
Pre Market
Last Updated: 07:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 68.59 07:00:00
Open Price Low Price High Price Close Price Prev Close
68.59
more quote information »

Recent News

Date Time Source Heading
11/22/202307:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
11/21/202307:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
11/06/202316:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202307:05EDGAR2Form 8-K - Current report
11/06/202307:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
11/06/202306:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
11/02/202307:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
10/31/202307:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
10/24/202307:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
10/11/202317:03EDGAR2Form 8-K - Current report
10/11/202307:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202307:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
10/02/202307:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
9/21/202307:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
9/15/202318:32EDGAR2Form 144 - Report of proposed sale of securities
9/15/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202307:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
9/05/202307:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
8/15/202307:45EDGAR2Form 8-K - Current report
8/07/202317:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:02EDGAR2Form 8-K - Current report
8/07/202307:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
8/04/202316:49EDGAR2Form 8-K - Current report
7/12/202307:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
7/07/202316:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/07/202308:21EDGAR2Form 8-K - Current report
7/07/202307:00GLOBEAxsome Therapeutics Initiates FOCUS Phase 3 Trial of..
6/30/202316:05EDGAR2Form 8-K - Current report
6/30/202316:02GLOBEAxsome Therapeutics Announces Closing of Public Offering of..
6/28/202309:28GLOBEAxsome Therapeutics Announces Pricing of Public Offering of..
6/27/202320:24GLOBEAxsome Therapeutics Announces Proposed Public Offering of..
6/01/202307:00GLOBEAxsome Therapeutics to Present New Sunosi® Data at SLEEP..
5/30/202307:00GLOBEAxsome Therapeutics to Present Data and Post-Hoc Analyses on..
5/08/202307:00GLOBEAxsome Therapeutics Reports First Quarter 2023 Financial..
5/03/202307:00GLOBEAxsome Therapeutics to Present at the Bank of America..
5/01/202307:00GLOBEAxsome Therapeutics Joins Mental Health America and the..
4/21/202307:00GLOBEAxsome Therapeutics to Present Five Abstracts Including New..
4/14/202307:00GLOBEAxsome Therapeutics to Present at the 22nd Annual Needham..
4/13/202307:00GLOBEAxsome Therapeutics to Report First Quarter 2023 Financial..
3/14/202309:30PRNUSSHAREHOLDER ALERT: Axsome Therapeutics, Inc. (AXSM) Officers..
3/01/202307:00GLOBEAxsome Therapeutics to Present at Cowen’s 43rd Annual Health..
2/27/202307:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
2/22/202307:00GLOBEAxsome Therapeutics Enters into License Agreement with..
2/07/202307:00GLOBEAxsome Therapeutics to Present at the SVB Securities Global..
1/31/202307:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
12/09/202211:05TRMNMizuho Securities Sticks to Their Buy Rating for Axsome..
12/07/202207:00GLOBEAxsome Therapeutics Presents New Data from the EVOLVE..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com